The pharmaceutical industry continues investing heavily into next-generation obesity therapies capable of improving efficacy and patient experience
Chromatographic purity (HPLC-UV/MS): 99.1% CJC-1295 content: 5.31 mg 106.2% of 5 mg label claim Ipamorelin content: 4.96 mg 99.1% of 5 mg label claim Mass spectral identity (both peptides): Confirmed View full third-party COA (PDF) All batch COAs are also listed at truvials.com/coa-library, searchable by batch number
Possible side effects include: Redness Itching Tingling Dryness Peeling Mild stinging Breakouts or small bumps Bruising or pain with injectable use Allergy-type reactions such as hives or swelling Stop using the product and seek medical care if you notice hives, swelling, trouble breathing, severe irritation, or symptoms that feel unusual for you
Monitoring B12 status before starting tirzepatide and periodically during therapy helps identify who truly needs supplementation versus those with adequate dietary intake
Everybody was giving you congratulations and good luck
Zethelius B, Eliasson B, Eeg-Olofsson K, Svensson AM, Gudbjornsdottir S, Cederholm J